Home › Biz Break: Gilead hepatitis C drugs rack up more huge sales, cash headed to investors
 

Keywords :   


Biz Break: Gilead hepatitis C drugs rack up more huge sales, cash headed to investors

2015-02-04 02:13:49| Biotech - Topix.net

Today: Gilead Sciences completes a transformational financial year with another huge quarter, thanks to sales of Foster City company's breakthrough hepatitis C medications, and will push that cash back to investors as discounts begin to take effect. Also: Twitter jumps amid changes.

Tags: to sales break cash

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
More »